Jason Del Vicario
Chemed Corporation
CHE-N
TOP PICK
Mar 08, 2021
They have been around for over 100 years. They survived the depression. They have interests in hospices and cleaning. They have dental supply as well. They have a long history of raising dividends and buybacks. He'd like to see it lower before buying. (Analysts’ price target is $595.00)
(A Top Pick Mar 08/21, Up 11%) Doesn't own stock anymore even though has recommended it to investors.
Flawed corporate governance. Management overpaid.
Will not buy in the future.
They have been around for over 100 years. They survived the depression. They have interests in hospices and cleaning. They have dental supply as well. They have a long history of raising dividends and buybacks. He'd like to see it lower before buying. (Analysts’ price target is $595.00)